دورية أكاديمية
أعرض في EDS

Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study.

التفاصيل البيبلوغرافية
العنوان: Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study.
المؤلفون: Jang W; Department of Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Kim S; Department of Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Son Y; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Kim S; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Kim HJ; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Regulatory Science, Kyung Hee University, Seoul, Republic of Korea., Jo H; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Regulatory Science, Kyung Hee University, Seoul, Republic of Korea., Park J; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Regulatory Science, Kyung Hee University, Seoul, Republic of Korea., Lee K; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Regulatory Science, Kyung Hee University, Seoul, Republic of Korea., Lee H; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Tully MA; School of Medicine, Ulster University, Londonderry, United Kingdom., Rahmati M; CEReSS-Health Service Research and Quality of Life Center, Aix-Marseille University, Marseille, France.; Department of Physical Education and Sport Sciences, Faculty of Literature and Human Sciences, Lorestan University, Khoramabad, Iran.; Department of Physical Education and Sport Sciences, Faculty of Literature and Humanities, Vali-E-Asr University of Rafsanjan, Rafsanjan, Iran., Smith L; Centre for Health, Performance and Wellbeing, Anglia Ruskin University, Cambridge, United Kingdom., Kang J; Division of Sleep Medicine, Harvard Medical School, Boston, MA, United States.; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, United States., Woo S; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Kim S; Department of Family Medicine, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Hwang J; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea., Rhee SY; Department of Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Regulatory Science, Kyung Hee University, Seoul, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Republic of Korea., Yon DK; Department of Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Department of Regulatory Science, Kyung Hee University, Seoul, Republic of Korea.; Department of Pediatrics, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
المصدر: JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Aug 27; Vol. 10, pp. e59571. Date of Electronic Publication: 2024 Aug 27.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101669345 Publication Model: Electronic Cited Medium: Internet ISSN: 2369-2960 (Electronic) Linking ISSN: 23692960 NLM ISO Abbreviation: JMIR Public Health Surveill Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Toronto : JMIR Publications, [2015]-
مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/therapy , COVID-19*/epidemiology , Health Knowledge, Attitudes, Practice*, Humans ; Republic of Korea/epidemiology ; Male ; Middle Aged ; Female ; Cross-Sectional Studies ; Prevalence ; Adult ; Aged ; Nutrition Surveys
مستخلص: Background: Type 2 diabetes poses an increasing disease burden in South Korea. The development and management of type 2 diabetes are closely related to lifestyle and socioeconomic factors, which have undergone substantial changes over the past few decades, including during the COVID-19 pandemic.
Objective: This study aimed to investigate long-term trends in type 2 diabetes prevalence, awareness, treatment, and control. It also aimed to determine whether there were substantial alterations in the trends during the pandemic and whether these changes were more pronounced within specific demographic groups.
Methods: This study examined the prevalence, awareness, treatment, and control of type 2 diabetes in a representative sample of 139,786 South Koreans aged >30 years, using data from the National Health and Nutrition Examination Survey and covering the period from 1998 to 2022. Weighted linear regression and binary logistic regression were performed to calculate weighted β coefficients or odds ratios. Stratified analyses were performed based on sex, age, region of residence, obesity status, educational background, household income, and smoking status. β (difference) was calculated to analyze the trend difference between the prepandemic period and the COVID-19 pandemic. To identify groups more susceptible to type 2 diabetes, we estimated interaction terms for each factor and calculated weighted odds ratios.
Results: From 1998 to 2022, a consistent increase in the prevalence of type 2 diabetes was observed among South Koreans, with a notable rise to 15.61% (95% CI 14.83-16.38) during the pandemic. Awareness followed a U-shaped curve, bottoming out at 64.37% (95% CI 61.79-66.96) from 2013 to 2015 before increasing to 72.56% (95% CI 70.39-74.72) during the pandemic. Treatment also increased over time, peaking at 68.33% (95% CI 65.95-70.71) during the pandemic. Control among participants with diabetes showed no substantial change, maintaining a rate of 29.14% (95% CI 26.82-31.47) from 2020 to 2022, while control among treated participants improved to 30.68% (95% CI 27.88-33.48). During the pandemic, there was a steepening of the curves for awareness and treatment. However, while the slope of control among participants being treated increased, the slope of control among participants with diabetes showed no substantial change during the pandemic. Older populations and individuals with lower educational level exhibited less improvement in awareness and control trends than younger populations and more educated individuals. People with lower income experienced a deceleration in prevalence during the pandemic.
Conclusions: Over the recent decade, there has been an increase in type 2 diabetes prevalence, awareness, treatment, and control. During the pandemic, a steeper increase in awareness, treatment, and control among participants being treated was observed. However, there were heterogeneous changes across different population groups, underscoring the need for targeted interventions to address disparities and improve diabetes management for susceptible populations.
(©Wonwoo Jang, Seokjun Kim, Yejun Son, Soeun Kim, Hyeon Jin Kim, Hyesu Jo, Jaeyu Park, Kyeongmin Lee, Hayeon Lee, Mark A Tully, Masoud Rahmati, Lee Smith, Jiseung Kang, Selin Woo, Sunyoung Kim, Jiyoung Hwang, Sang Youl Rhee, Dong Keon Yon. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 27.08.2024.)
References: Lancet Reg Health West Pac. 2023 Dec 01;43:100842. (PMID: 38456094)
Diabetes Care. 2021 Dec;44(12):2645-2655. (PMID: 34625431)
JAMA Netw Open. 2023 Jun 1;6(6):e2316930. (PMID: 37273204)
Diabetes Care. 2023 Jul 1;46(7):1335-1344. (PMID: 36854188)
Diabetes Res Clin Pract. 2020 Sep;167:108350. (PMID: 32710996)
J Gen Intern Med. 2012 Dec;27(12):1674-81. (PMID: 22854982)
Endocr Rev. 2024 Mar 4;45(2):281-308. (PMID: 37934800)
Am J Mens Health. 2015 Sep;9(5):370-9. (PMID: 25122719)
J Med Virol. 2023 Jan;95(1):e28100. (PMID: 36029131)
Sci Rep. 2023 Oct 4;13(1):16727. (PMID: 37794087)
Int J Epidemiol. 2014 Feb;43(1):69-77. (PMID: 24585853)
Popul Health Manag. 2022 Jun;25(3):407-412. (PMID: 34870474)
BMC Public Health. 2009 Jun 30;9:213. (PMID: 19563685)
JAMA Netw Open. 2022 Oct 3;5(10):e2231633. (PMID: 36227600)
Osong Public Health Res Perspect. 2019 Aug;10(4):205-214. (PMID: 31497491)
Diabetes. 2019 Feb;68(2):291-304. (PMID: 30487265)
Lancet Reg Health West Pac. 2021 Jan 23;7:100085. (PMID: 34327415)
JAMA. 2022 May 3;327(17):1706. (PMID: 35503354)
Eur J Nutr. 2024 Feb;63(1):279-289. (PMID: 37999737)
BMC Med. 2023 Feb 10;21(1):47. (PMID: 36765407)
Lancet. 2023 Jul 15;402(10397):203-234. (PMID: 37356446)
South Med J. 2015 Jan;108(1):29-36. (PMID: 25580754)
BMC Public Health. 2022 Jun 18;22(1):1216. (PMID: 35717151)
Diabetologia. 2023 Feb;66(2):255-266. (PMID: 36418578)
J Korean Med Sci. 2021 Oct 25;36(41):e291. (PMID: 34697932)
Lancet Diabetes Endocrinol. 2017 Nov;5(11):839. (PMID: 29082880)
J Womens Health (Larchmt). 2017 Feb;26(2):178-185. (PMID: 27705079)
Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):1889-1903. (PMID: 36930486)
Nat Commun. 2023 Aug 17;14(1):4989. (PMID: 37591837)
Lancet. 2024 May 18;403(10440):2133-2161. (PMID: 38642570)
Int J Equity Health. 2019 Sep 18;18(1):148. (PMID: 31533732)
J Clin Endocrinol Metab. 2016 Oct;101(10):3740-3746. (PMID: 27490920)
Can J Diabetes. 2020 Jul;44(5):448-452. (PMID: 32127295)
J Family Med Prim Care. 2020 Sep 30;9(9):4623-4626. (PMID: 33209773)
Diabetes Metab J. 2022 Sep;46(5):803-807. (PMID: 35581145)
Korean J Intern Med. 2023 Jan;38(1):93-100. (PMID: 36420563)
Nat Med. 2024 Jan;30(1):51-60. (PMID: 38242981)
BMC Public Health. 2021 Jun 5;21(1):1068. (PMID: 34090396)
Diabetes Obes Metab. 2018 Nov;20(11):2642-2652. (PMID: 29934972)
Sci Rep. 2023 Dec 8;13(1):21724. (PMID: 38066091)
Lancet Reg Health West Pac. 2023 Sep 21;41:100904. (PMID: 37780633)
Diabetes Metab J. 2022 May;46(3):417-426. (PMID: 35656565)
Diabetes Care. 2003 Sep;26(9):2543-8. (PMID: 12941716)
Diabetes Res Clin Pract. 2018 Apr;138:57-65. (PMID: 29412145)
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2262-2271.e2. (PMID: 33931377)
JAMA Netw Open. 2023 Aug 1;6(8):e2330024. (PMID: 37603333)
فهرسة مساهمة: Keywords: Republic of Korea; disease management; epidemiology; prevalence; type 2 diabetes mellitus
تواريخ الأحداث: Date Created: 20240827 Date Completed: 20240827 Latest Revision: 20240914
رمز التحديث: 20240914
مُعرف محوري في PubMed: PMC11387923
DOI: 10.2196/59571
PMID: 39190907
قاعدة البيانات: MEDLINE
الوصف
تدمد:2369-2960
DOI:10.2196/59571